Literature DB >> 12745265

Rituximab: a new therapeutic tool for primary immune thrombocytopenic purpura?

Martino Introna, Josée Golay, Tiziano Barbui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12745265

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  2 in total

Review 1.  Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies.

Authors:  Ronald P Taylor; Margaret A Lindorfer
Journal:  Curr Opin Immunol       Date:  2008-07-01       Impact factor: 7.486

2.  Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions.

Authors:  G Vannucchi; I Campi; M Bonomi; D Covelli; D Dazzi; N Currò; S Simonetta; P Bonara; L Persani; C Guastella; J Wall; P Beck-Peccoz; M Salvi
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.